相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Improved transplant survival and long-term disease outcome in children with MHC class II deficiency
Su Han Lum et al.
BLOOD (2020)
A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report
Farhad Abolnezhadian et al.
IMMUNOLOGIC RESEARCH (2020)
Primary immunodeficiency
Christine McCusker et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
Cytomegalovirus Retinitis: A Review
Alexander D. Port et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management
Seza Ozen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Practice parameter for the diagnosis and management of primary immunodeficiency
Francisco A. Bonilla et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Severe combined immunodeficiencies and related disorders
Alain Fischer et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
MHC class I and II deficiencies
Suheir Hanna et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Alternative donor SCT for the treatment of MHC Class II deficiency
T. N. Small et al.
BONE MARROW TRANSPLANTATION (2013)
Major Histocompatibility Complex Class II Deficiency in Kuwait: Clinical Manifestations, Immunological Findings and Molecular Profile
Waleed Al-Herz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
The Risk of Familial Mediterranean Fever in MEFV Heterozygotes: A Statistical Approach
Isabelle Jeru et al.
PLOS ONE (2013)
A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED)
Alessandra Fierabracci et al.
GENE (2012)
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy: Insights into Genotype-Phenotype Correlation
Donatella Capalbo et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2012)
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients
Monia Ouederni et al.
BLOOD (2011)
Allogeneic Stem Cell Transplantation Using Myeloablative and Reduced-Intensity Conditioning in Patients with Major Histocompatibility Complex Class II Deficiency
Hamoud Al-Mousa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
The Transcription Factor RFX Protects MHC Class II Genes against Epigenetic Silencing by DNA Methylation
Queralt Seguin-Estevez et al.
JOURNAL OF IMMUNOLOGY (2009)
Adrenal insufficiency associated with cytomegalovirus infection in two infants
Ener Cagri Dinleyici et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Transcriptional silencing of RFXAP in MHC class II-deficiency
Marja C. J. A. van Eggermond et al.
MOLECULAR IMMUNOLOGY (2008)
Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency:: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections
Raffaele Renella et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric AIDS clinical trials group P1009 study
WT Shearer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
MHC class II deficiency - A disease of gene regulation
J Villard et al.
MEDICINE (2001)
Clinical course of patients with major histocompatibility complex class II deficiency
MA Saleem et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2000)
Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter
XS Zhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)